Llwytho...
2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure
We are developing a novel treatment for heart failure by increasing myocardial 2 deoxy-ATP (dATP). Our studies in rodent models have shown that substitution of dATP for adenosine triphosphate (ATP) as the energy substrate in vitro or elevation of dATP in vivo increases myocardial contraction and tha...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Mol Cell Cardiol |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2014
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4301986/ https://ncbi.nlm.nih.gov/pubmed/25498214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2014.12.002 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|